CRLF2 defects in Down syndrome-associated leukemia
Nature Genetics
October 19, 2009
A chromosomal alteration that fuses the P2RY8 and CRLF2 genes is found in individuals with B-progenitor acute lymphoblastic leukemia (ALL) and ALL associated with Down syndrome (DS), according to a new study published online this week in Nature Genetics.
ALL is the most common childhood cancer, with a cure rate of 85% in children. Children with DS are approximately 10-20 times more likely to develop leukemia than non-DS children.
Charles Mullighan and colleagues report that a recurrent chromosomal deletion that leads to the P2RY8-CRLF2 fusion is found in 7% of individuals with B-progenitor ALL and 53% of individuals with Down syndrome-associated ALL. The fusion leads to elevated activity of the CRLF2 gene, which may contribute to the increased risk of ALL in children with DS.
doi: 10.1038/ng.469
Research highlights
-
Sep 20
Cell biology: Endocannabinoid system may be involved in human testis physiologyScientific Reports
-
Sep 19
Health: Birth mode linked to microbiome disruptionNature
-
Sep 18
Ecology: Stress-resistant corals maintain heat tolerance under cooler temperaturesNature Communications
-
Sep 12
Stem cells: Modelling early human embryo developmentNature
-
Sep 11
Zoology: New electric eel species produces quite a shockNature Communications
-
Sep 11
Evolution: A virtual skull of modern humans’ last common ancestorNature Communications
